BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11

• Press Releases

  Minerva Neurosciences to Participate in The Citizens Life Sciences Conference

  March 4, 2026

   · 

  1 min read
• Press Releases

  Harrow to Present at Leerink Partner’s 2026 Global Healthcare Conference

  March 4, 2026

   · 

  1 min read
• Press Releases

  Pulse Biosciences’ nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting

  March 4, 2026

   · 

  4 min read
• Press Releases

  NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs

  March 4, 2026

   · 

  9 min read
• Press Releases

  Affinia Therapeutics Granted FDA Fast Track Designation for AFTX-201 as a Treatment for People Living with BAG3-Associated Dilated Cardiomyopathy (DCM)

  March 4, 2026

   · 

  4 min read
• Press Releases

  Landmark Data Validate BrainsWay’s SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment

  March 4, 2026

   · 

  8 min read
• Press Releases

  CervoMed Announces Selection of Formulation and Dosing Regimen for Planned Phase 3 Trial in Patients with Dementia with Lewy Bodies

  March 4, 2026

   · 

  8 min read
• Press Releases

  MIRA Pharmaceuticals Completes Phase 1 Dosing of Ketamir-2

  March 4, 2026

   · 

  6 min read
• Press Releases

  BridgeBio to Present Additional Data from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical & Scientific Conference

  March 4, 2026

   · 

  2 min read
• Press Releases

  KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2026

  March 4, 2026

   · 

  1 min read